August 9, 2007 - Deep Breeze announced that the FDA has granted 510K marketing clearance for the VRIXP, a non-invasive, radiation-free pulmonary imaging system that uses lung sounds to create dynamic images of the lungs.
Deep Breeze plans to launch VRIXP in the U.S. at the 2007 CHEST meeting in Chicago, Oct. 20 to 25.
The system records lung sounds from sensors applied to a patient’s back and then uses an algorithm to convert these data into images. According to the company, changes in tissue composition or alteration in airflow impact how sounds within the lungs vibrate, and subsequently how the VRIXP images appear on the system's computer screen.
"The VRIXP system is a breakthrough technology that may allow us to improve patient care by providing more detailed and rapid assessment of lung status without exposing the patient to radiation," said Kalpalatha K. Guntupalli, M.D., Professor of Medicine, Chief, Pulmonary, Critical Care, and Sleep Medicine, Baylor College of Medicine.
"This technology shows great promise for assisting in the care and management of critically ill patients as well as patients with a wide variety of acute cardiopulmonary problems," Dr. R. Phillip Dellinger, Professor of Medicine at Robert Wood Johnson Medical School and Director of the Critical Care Division, Department of Medicine, Cooper University Hospital, said.
For more information: www.deepbreeze.com
July 23, 2026 
